Guide

Ipamorelin Legal Status & Compounding (2026)

Ipamorelin legal status in 2026. FDA classification, compounding pharmacy availability, research chemical access, WADA ban, and CJC-1295 combination.

Ipamorelin is best known as one half of the CJC-1295/Ipamorelin stack — the most prescribed GH peptide combination in US anti-aging medicine. Its legal status is favorable: available through multiple channels with no current restrictions.

StatusIpamorelin
FDA-approvedNo
Category 2 restrictedNo
Controlled substanceNo
Compounding availableYes (with Rx)
Research chemical availableYes
WADA prohibitedYes

The CJC-1295/Ipamorelin Combination

Most people encounter ipamorelin as part of the CJC-1295/Ipamorelin combination. The legal status of the combination is straightforward:

  • Both compounds are legal — neither is Category 2 or controlled
  • Compounding is legal — combination vials are produced by 503A and 503B pharmacies
  • Prescription required from compounding pharmacies; not required from research vendors
  • Typical compounded product: Pre-mixed vial containing CJC-1295 (no DAC) + Ipamorelin in a single reconstituted injection

Why This Combo Is So Common

The CJC-1295/Ipamorelin combination has become the “default” GH peptide protocol because:

  1. Synergistic mechanism — CJC-1295 stimulates GH release (GHRH pathway), ipamorelin amplifies it (ghrelin pathway). Together they produce stronger, more natural GH pulsing than either alone.
  2. Clean side effect profile — ipamorelin does not significantly raise cortisol or prolactin (unlike GHRP-2/GHRP-6), making the combination well-tolerated
  3. Established clinical protocols — over a decade of anti-aging clinic use with documented outcomes
  4. Prescriber familiarity — most wellness providers are comfortable prescribing this combination

Access Pathways

Compounding Pharmacy

FeatureDetails
ProductCJC-1295 (no DAC) + Ipamorelin combination vial
PrescriptionRequired
Cost$150-350/month
QualityPharmacy-grade
ConveniencePre-mixed, precise dosing

Research Chemical

FeatureDetails
ProductIpamorelin lyophilized powder (separate from CJC-1295)
PrescriptionNot required
Cost$25-45 per vial (5mg)
QualityVaries — verify with CoA
NotesMust purchase CJC-1295 separately and mix yourself

Telehealth

FeatureDetails
ProductCJC-1295/Ipamorelin via partner compounding pharmacy
Cost$200-400/month (includes consultation)
ConvenienceOnline visit, shipped to door

Category 2 Risk Assessment

Like CJC-1295, ipamorelin faces some risk of future compounding restrictions:

Risk factors:

  • Widely compounded with no FDA approval history
  • Growing market visibility
  • FDA reviewing additional peptides

Mitigating factors:

  • No competing pharmaceutical product
  • Clean safety track record
  • FDA enforcement focused elsewhere (GLP-1s, BPC-157)
  • Always prescribed in combination — restricting ipamorelin alone is less likely than restricting the combination

Assessment: Low-to-medium risk in 2026. If restrictions come, they would likely target the CJC-1295/Ipamorelin combination as a category rather than ipamorelin alone.

WADA Prohibition

DetailStatus
WADA categoryS2 — Growth Hormone Secretagogues
TimingProhibited at all times
Combination statusCJC-1295/Ipamorelin also prohibited
DetectionUrine testing — detectable for days after last injection

Frequently Asked Questions

Is ipamorelin legal in 2026? +

Yes. Ipamorelin is legal to purchase and possess in the United States. It is not FDA-approved, not a controlled substance, and has not been placed on the FDA's Category 2 list. It is available from compounding pharmacies (with a prescription) and research chemical vendors (without a prescription).

Can I get ipamorelin from a compounding pharmacy? +

Yes. Ipamorelin is commonly available from compounding pharmacies, almost always in combination with CJC-1295 (no DAC). This combination is one of the most prescribed peptide protocols in the anti-aging and wellness space. A prescription from a licensed provider is required.

Is the CJC-1295/Ipamorelin combination legal? +

Yes. Both CJC-1295 and ipamorelin are legal, and the combination product is widely compounded. Neither peptide is on the FDA's Category 2 list. The combination is the most commonly prescribed GH peptide protocol in US wellness clinics.

Is ipamorelin banned in sports? +

Yes. Ipamorelin is on the WADA Prohibited List under S2 as a growth hormone secretagogue. It is prohibited at all times — in-competition and out-of-competition. The CJC-1295/Ipamorelin combination is also prohibited. Tested athletes cannot use either compound.

How is ipamorelin different from sermorelin legally? +

The key legal difference: sermorelin has prior FDA approval (Geref, discontinued), while ipamorelin has never been FDA-approved. This gives sermorelin a stronger legal foundation — compounding pharmacies have more established legal standing to produce it, and prescribers may feel more comfortable. In practice, both are currently available from compounding pharmacies and research vendors.